This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Hologic Completes Cynosure Buyout, Boosts Core Business
by Zacks Equity Research
Hologic, Inc. (HOLX) recently announced the completion of it earlier declared acquisition of marketer of aesthetic treatment systems, Cynosure, Inc.
Cooper Companies (COO) Increase Share Repurchase Program
by Zacks Equity Research
The Cooper Companies, Inc. (COO) recently announced that it has approved a $500.0 million increase in its ongoing share repurchase program.
WellCare Health's Revenue Growth Strong, Rising Costs a Drag
by Zacks Equity Research
WellCare Health Plans, Inc. (WCG) stock has long been an investor favorite owing to strong fundamentals.
Align's iTero Hits 1 Billion Mark, Boosts Scanner Business
by Zacks Equity Research
Align Technology Inc. (ALGN) has recently revealed that more than one million scans have been submitted using its iTero Element scanner in less than two years.
Genomic Health's Cancer Test Business Strong, Expenses High
by Zacks Equity Research
On Mar 20, we issued an updated research report on Redwood City, CA-based Genomic Health Inc. (GHDX), a leading global cancer company with a focus on advanced molecular diagnostics.
HealthEquity (HQY) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
HealthEquity Inc (HQY) reported earnings of 7 cents per share in the fourth quarter of 2016, higher than the Zacks Consensus Estimate of 5 cents.
DENTSPLY Sirona Grapples with Multiple Issues: Dump Now?
by Zacks Equity Research
On Mar 20, we issued an updated research report on NY-based DENTSPLY Sirona Inc. (XRAY) -- a global leader in the design, development, manufacture and marketing of dental consumables and dental laboratory products.
Neogen (NEOG) Earnings and Revenues Meet Estimates in Q3
by Zacks Equity Research
Neogen Corp (NEOG) reported adjusted earnings of 27 cents per share in the third quarter of fiscal 2017. The figure was in line with the Zacks Consensus Estimate and increased 22.7% from the year-ago quarter.
Merit Medical (MMSI) to Refinance Debt via Share Offering
by Zacks Equity Research
Merit Medical Systems, Inc. (MMSI) announced that it has commenced a follow on public offering of its common stock.
Integer (ITGR) Amends Term B Loan to Lower Interest Rate
by Zacks Equity Research
Integer Holdings Corporation (ITGR) announced that it has completed an amendment to its senior secured credit facilities to lower the interest rate on its Term B Loan Facility.
Genomic Health's Breast Recurrence Test Data Encouraging
by Zacks Equity Research
Genomic Health, Inc. (GHDX), a leading molecular diagnostics company, recently presented results from 15 Oncotype DX Breast Recurrence Score studies.
Medtronic's Positive 2-Year SURTAVI Data Boosts Corevalve
by Zacks Equity Research
Medtronic plc (MDT) has released the first-ever clinical data from the Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) Trial.
Abbott Laboratories' MitraClip Outcome Positive for DMR
by Zacks Equity Research
Abbott Laboratories (ABT) recently presented one-year positive outcomes from the study of the MitraClip system in transcatheter mitral valve repair (TMVR) procedures in the U.S.
Fresenius (FMS) to Jointly Develop Acumen with Epic Systems
by Zacks Equity Research
Fresenius Medical Care AG & Co. KGAA (FMS) announced that it would jointly develop Acumen 2.0 with Epic Systems Corporation.
Thermo Fisher Poised on Innovation, Global Growth Amid Woes
by Zacks Equity Research
On Mar 17, 2017, we issued an updated research report on Thermo Fisher Scientific Inc. (TMO).
PharMerica Takes Over CareMed, Expands in Specialty Pharmacy
by Zacks Equity Research
PharMerica Corporation (PMC) recently announced the acquisition of CareMed Specialty Pharmacy, a leading provider of specialty pharmacy services. However, all the other terms of the deal have been kept under wraps.
Air Methods (AIRM) Opens New Training Facility in Colorado
by Zacks Equity Research
Air Methods Corporation (AIRM) announced the opening of new FlightSafety Learning Center in Denver, CO.
CVS Health Launches Reduced Rx for Affordable Medication
by Zacks Equity Research
CVS Health Corporation (CVS), a leading name in pharmacy benefit and retail pharmacy, recently announced the launch of a prescription savings program-Reduced Rx.
STERIS Continues to Trade Below Industry on Dull Outlook
by Zacks Equity Research
On Mar 16, we issued an updated research report on Ohio-based STERIS plc (STE).
3 Medical Device Stocks to Brave Policy Uncertainty
by Zacks Equity Research
We believe stocks with strong fundamentals that also have a significant share of their business overseas may well brace themselves in the on-going conundrum. They will make lucrative additions to your portfolio.
Integra (IART) Titan Reverse Launch Expands Extremity Line
by Zacks Equity Research
Integra LifeSciences (IART) recently broadened its extremity product line with the launch of its Titan Press-Fit Reverse Shoulder for Fracture.
Medtronic's Melody TPV Wins FDA for Less-Invasive Treatment
by Zacks Equity Research
Medtronic plc (MDT) recently won FDA approval for Melody Transcatheter Pulmonary Valve for implantation in patients whose surgical bioprosthetic pulmonary heart valves have failed.
Align Technology Hits a 52-Week High on Solid Prospects
by Zacks Equity Research
Share price of San Jose, CA-based Align Technology, Inc. (ALGN) reached a new 52-week high of $110.87 on Mar 15, eventually closing a bit lower at $110.31.
Zacks.com featured highlights: Potbelly, Inogen, U.S. Silica Holdings, NextEra Energy Partners and Diamondback Energy
by Zacks Equity Research
Zacks.com featured highlights: Potbelly, Inogen, U.S. Silica Holdings, NextEra Energy Partners and Diamondback Energy
Your Guide to the Stock Winners & Losers of Trump's Obamacare Replacement Bill
by Madeleine Johnson
Whether you think it???s "Obamacare Lite," "Obamacare 2.0," "dead on arrival" like Rand Paul, or you actually like the bill, the American Healthcare Act (AHCA) has certainly made an impact on the entire healthcare industry since its announcement. Who are the stock winners and losers so far? And who will be affected if it's passed?